GLP-1 and GIP medications have changed the conversation around weight loss. For many people, they have been life-changing, but there’s a question we hear often in clinic: what happens to your weight, and your metabolic health, once you stop? GLP-1 weight regain is real, and understanding why it happens is the first step to protecting your results.

How these medications actually work

Incretin medications keep the “you’ve eaten” signal switched on. Normally that signal fades within moments of finishing a meal. On these medications, it can last a week. That is what makes appetite feel so quiet, so manageable, for the first time in years for some people.

But a switch that gets turned on by medication can also get turned off when the medication stops, and that is where things get harder.

The reality of stopping: why GLP-1 weight regain happens

Research following people after they discontinue incretin therapy paints a clear picture. Around 60% of the weight lost is regained within a year, with only a 4 to 5% net loss tending to persist long term.

Metabolic health follows the same pattern. About half the improvement in HbA1c is gone within 8 to 12 weeks, and rarely returns fully to baseline. Blood pressure behaves the same way, with 70 to 80% of the improvement regained within 12 weeks of stopping.

This is what the body does when a powerful external signal is removed and nothing has replaced it underneath.

What the long-term maintainers do differently

The National Weight Control Registry, a US-based study, has tracked over 10,000 adults who lost an average of 32kg and kept it off for five years or more. Their habits tell a consistent story:

    • 90% move their body for 60 minutes most days

    • 78% eat breakfast daily

    • 75% weigh in at least weekly

    • 62% limit screen time to under 10 hours a week

The common thread is consistency.

A consistent diet

A lower-calorie, lower-fat pattern, around 1,381 kcal a day, eaten much the same way on weekdays, weekends and holidays.

Movement as a habit

98% changed how they ate and 94% increased their activity, averaging roughly 2,600 kcal a week, mostly through walking.

Early course-correction

High dietary restraint, low disinhibition, and small regains caught quickly through routine self-weighing, before they become large ones.

What it tells us

Effort offsets biology

The body adapts to weight loss by trying to pull weight back on. Consistent activity is one of the few things that reliably counters that pull.

There is a critical time threshold

Getting past roughly two years of maintenance sharply improves the odds that the change holds for good.

The approach is method agnostic

Appetite control, consistency and movement are the underlying mechanics of durable results, whether they are built through lifestyle change, nutraceutical support or incretin therapy.

Where naturopathic care fits in

This is the piece that often gets left out of the GLP-1 conversation. Medication can create the window of opportunity. What you build inside that window is what determines whether the change lasts.

At GHE, this is where we support people, before starting a medication, alongside one, or after coming off it. Looking at appetite regulation, blood sugar balance, nervous system load and daily habits, so the body has genuine support underneath the number on the scale.

Sustainable change is about giving your body consistent, personalised support long enough for new patterns to become the default.

Wherever you are in this process, considering a GLP-1 medication, currently on one, or thinking about your next step after stopping, the first move is simply understanding what your body actually needs. Our free discovery call is where that conversation starts.

Book your free discovery call with us and let’s talk through a personalised approach to your metabolic health.

References

Klem, M. L., Wing, R. R., McGuire, M. T., Seagle, H. M., & Hill, J. O. (1997). A descriptive study of individuals successful at long-term maintenance of substantial weight loss. American Journal of Clinical Nutrition, 66(2), 239–248. https://doi.org/10.1093/ajcn/66.2.239

Wadden, T. A., Chao, A. M., Moore, M., Tronieri, J. S., Gilden, A., Amaro, A., Leonard, S., & Jakicic, J. M. (2023). The role of lifestyle modification with second-generation anti-obesity medications: Comparisons, questions, and clinical opportunities. Current Obesity Reports, 12(4), 453–473. https://doi.org/10.1007/s13679-023-00534-z

Wing, R. R., & Phelan, S. (2005). Long-term weight loss maintenance. American Journal of Clinical Nutrition, 82(1 Suppl), 222S–225S. https://doi.org/10.1093/ajcn/82.1.222S